This message was sent to AIM, FAB, Health Systems, INE, IAP, LHD Health Officers, LHD Medical Directors, MACI, MACI 2, PH Imms Leads, COVID-19 Vaccine Providers, and Imms All Staff. I apologize for any duplications.

Hello Immunization Partners,

Please share the following information with providers in your jurisdiction.

As a reminder, 2024 Immunization Schedules for Clinicians were published in November 2023. On January 11, 2024, the Centers for Disease Control and Prevention (CDC) published two MMWR reports summarizing the 2024 updates to CDC’s immunization schedules.

• Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger —United States, 2024
• Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older—United States, 2024

The 2024 Child and Adolescent Immunization Schedule includes new recommendations for:

• Respiratory syncytial virus (RSV) vaccine,
• Respiratory syncytial virus (RSV) monoclonal antibody,
• Mpox vaccine,
• 20-valent pneumococcal conjugate vaccine, and
• Pentavalent meningococcal vaccine

The 2024 Adult Immunization Schedule includes new recommendations for:

• Respiratory syncytial virus (RSV) vaccine,
• Mpox vaccine, and
• Pentavalent meningococcal vaccine

Both schedules also include updated recommendations for 2023-2024 formula COVID-19 vaccine, influenza vaccines, and inactivated poliovirus vaccine (IPV).

Below are resources for patients to assist them with understanding which vaccines are recommended for adults and children:

• Adult Easy-to-Read Schedule (English and Spanish)
• Childhood and Adolescent Assessment Tool
• Vaccines You Need as an Adult

Thank You for all you do!
The Immunization Outreach and Education Team,
Alyssa, Andrea, Dianne, Heidi, Lisa, and Sarah